Kuru and Mad Cow Disease: Understanding the Prion Theory

Total Page:16

File Type:pdf, Size:1020Kb

Load more

MEDICAL GRAND ROUNDS LLIAM S. WILKE, MD, EDITOR TAKE-HOME POINTS FROM EDUCATIONAL PRESENTATIONS BY CLEVELAND CLINIC FACULTY AND VISITING PROFESSORS Kuru and mad cow disease: Understanding the prion theory G. RICHARD OLDS, MD • NEW GUINEA, 1957: Chairman, Department of Medicine, MetroHealth Medical Center, Cleveland; A NEW DISEASE AMONG THE CANNIBALS Charles H. Rammelkamp Jr. Professor of Medicine, Case Western Reserve University College of Medicine; expert in geographic medicine and tropical disease. Chaired a number of committees for the World Health Organization, Shortly after World War II, stories began to circulate among colonial authorities about a • ABSTRACT strange neurologic disease affecting the Fore A preponderance of evidence indicates that (pronounced four-ay) people of the remote several neurodegenerative disorders are highlands of Papua, New Guinea, one of the caused by prions: abnormally folded proteins most isolated and primitive areas in the world. that can induce abnormal folding in other In 1957, Dr. Carleton Gajdusek began work normal protein molecules. Further, these among the Fore, which would occupy him for "infections" can cross some species barriers. many years and eventually win him the Nobel Prize in 1976.2 OR DECADES, the causative agents of dif- The disease that Gajdusek found was like ferent spongiform encephalopathies in no other he had ever seen. Victims were pre- man and animals, such as kuru, scrapie, and dominately women and children. The tribes- Creutzfeldt-Jakob disease, were a mystery. The people called the disease kuru (trembling, diseases were transmissible, but the victims shaking), because of one of its prominent signs. Prions have showed no clinical or pathological signs of Other signs were psychiatric changes, inappro- forced us to infection. Cultures of victims' brains revealed priate affect (including inappropriate laugh- nothing. Further, usual sterilization procedures ter), and cerebellar ataxia. Dementia occurred rethink our did not destroy the agents' infectivity. only late in the disease, if at all. Once the signs ideas about The implication of these findings seemed appeared, the disease invariably progressed preposterous: the agent consisted of protein within months to complete debilitation and infectious alone, with no nucleic acid at all. Such a the- death.3 agents ory would violate all known concepts of infec- The brains of the victims, preserved in tion. Yet it was precisely this theory that Dr. formaldehyde and sent to the NIH for patho- Stanley Prusiner proposed in 1982,1 and for logic analysis, showed changes similar to which he was awarded the Nobel Prize in 1997. those produced by scrapie, a disease of sheep. With the recent controversy in England Specifically, the cerebellums contained over bovine spongiform encephalopathy florid amyloid plaques and spongiform (BSE), better known as mad cow disease, and changes—literally, spongelike holes where its apparent jump to humans, there is a grow- neurons used to be.4 ing understanding that prions are not just a Studies in chimpanzees confirmed what medical curiosity, but a potentially grave pub- epidemiologic studies suggested: the disease lic health threat. was transmissible.5 Extracts from the brains of This brief article presents a short history of human victims, injected into chimps, resulted the development of the prion theory of disease, in a disease very much like the human disease, an overview of that theory, and some of the and extracts from the infected chimps' brains lessons that our understanding of kuru and mad could in turn induce the disease in other cow disease holds for contemporary society. chimps. Yet, as with scrapie, workers could find CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 65 • NUMBER 6 JUNE 1998 291 Downloaded from www.ccjm.org on October 6, 2021. For personal use only. All other uses require permission. MEDICAL GRAND ROUNDS ease, and to growth hormone extracted from human cadavers.7 A..», 4~ y • •• t»V' *!«v • UNITED STATES, 1982: THE PRION THEORY PROPOSED ! • i* <* „ J - * - • r •*«»* ; y* -v. Noting that the infectious agents in kuru, - •••> « » * , ; i •• *• v « • >• • r 5. ... '.¿J ' v scrapie, and Creutzfeldt-Jakob disease were — » . Ci. • * •* - "if impervious to normal sterilization procedures, • . /" , ^ -'' * • • « V », •*; v and were not destroyed by electron radiation < *v . .. >a •»$ \ ••» or ultraviolet light at a wavelength specifical- ; / - t s «? *• * u» ly absorbed by nucleic acids, scientists began ' • yi # . * , - 4 * • '-./A, , • to develop an alternate theory, that proteins v • r * , alone were responsible for these diseases.1 In this theory, a naturally occurring pro- •HHKHiHHHilHH tein is transformed into a mutant form—a FIGURE 1. Brain tissue from a patient with Creutzfeldt-Jakob "prion"—that is then able to convert proteins disease, showing the characteristic spongiform changes. with normal three-dimensional structures to SOURCE: COURTESY OF RICHARD A. PRAYSON, MD. the mutant form, giving an infectious proper- ty to this inanimate protein. no trace of an agent, either bacterium or virus. Further, victims showed no signs of infection, Normal prion protein such as fever or adenopathy. Workers at that Within the neurons of most mammals is a pro- time speculated that kuru, scrapie, and similar tein, called prion protein (PrP). This prion diseases were caused by "slow viruses," protein, which is naturally produced in the although the actual agent eluded them. cytoplasm, has a phospholipid anchor and Gajdusek and others eventually linked kuru appears to bind to the cell membrane. to ritual cannibalism. Women and children The function of normal prion protein is ln prion comprised most of the kuru victims because unclear. Genetically engineered mice that diseases, the they, and not men, consumed the brains of their cannot produce prion protein grow and repro- family members who had died. The women duce normally. These "knockout" mice exhib- normal shared this protein meal with the small children it only subtle abnormalities, such as altered protein shape that always accompanied them. Adult men, circadian rhythms, progressive but mild atax- who ate the flesh, were largely unaffected. After ia, and decreased gamma-aminobutyric acid mutates cannibalism was eliminated in the 1960s, the (GABA)-mediated synaptic inhibition. This incidence of kuru steadily declined. latter effect suggests that prion proteins are involved in regulating GABA activity. • UNITED STATES, 1974: However, these knockout mice cannot get IATROGENIC TRANSMISSION spongiform encephalopathies when injected OF CREUTZFELDT-JAKOB DISEASE with infectious prions, providing the best evi- dence to date in support of the prion. Creutzfeldt-Jakob disease is a rare, degenera- tive neurologic disease, also characterized by Structure of normal spongiform changes in the brain (FIGURE 1), and abnormal prion protein that usually occurs sporadically in persons in The backbone of normal prion protein is their 60s, although there is sometimes a twisted into spiral shapes known as "alpha hereditary linkage. In 1974, a case occurred in helices" (FIGURE 2). In prion diseases, the nor- a middle-aged woman who had received a mal shape of the protein is transformed, struc- corneal transplant from a donor with ture, with the spiral helices stretched out into Creutzfeldt-Jakob disease.6 Other cases were a flat configuration, known as beta sheets. linked to the use of brain electrodes previous- Normal prion protein survives in the neu- ly used in patients with Creutzfeldt-Jakob dis- rons for only a few hours, before it is digested 292 CLEVELAND CLINIC JOURNAL Of MEDICINE VOLUME 65 • NUMBER 6 JUNE 1998 Downloaded from www.ccjm.org on October 6, 2021. For personal use only. All other uses require permission. MEDICAL GRAND ROUNDS Hü! MIM prion protein, even though both normal and mutant protein configurations have the same Known prion diseases amino acid sequence. There are two theories Diseases in animals on how this transformation might occur. In the dimerization theory, it is thought Scrapie that a mutant prion protein molecule links Bovine spongiform encephalopathy Transmissible mink encephalopathy with a normal prion protein molecule, trans- Feline spongiform encephalopathy forming the latter's helical structure into the Exotic ungulate encephalopathy beta-sheet structure. Then the two mutant molecules disassociate and move on to trans- Diseases in man form more normal prion protein molecules. Kuru In the second theory, is a single beta-sheet "Spontaneous" Creutzfeldt-Jakob disease molecule in a neuron acts as a seed to trans- "Hereditary" Creutzfeldt-Jakob disease form the normal protein molecules into a crys- Gerstmann-Sträussler-Scheinker disease Fatal familial insomnia talline aggregation of abnormal protein. "New variant" Creutzfeldt-Jakob disease In either case, the presence of the mutant, (probably human bovine spongiform encephalopathy) beta-sheet protein or prion initiates a cascade of conversion to the abnormal form. Thus, prions act like infectious agents. Prions appear to be able to cross species barri- by proteases. However, the mutant, beta-sheet ers, but often after a marked lag time. Because formation, or "prion" cannot be degraded and prions are proteins, they are unaffected by instead accumulates in the neurons. It is this sterilization techniques designed to kill most accumulation of mutant protein that is bacteria and viruses. Cooking meat, for exam- believed to cause neuron destruction and the ple, does not inactivate
Recommended publications
  • A Review on Kuru: Fatal Neurodenegerative Disease”

    A Review on Kuru: Fatal Neurodenegerative Disease”

    IOSR Journal Of Pharmacy And Biological Sciences (IOSR-JPBS) e-ISSN:2278-3008, p-ISSN:2319-7676. Volume 15, Issue 3 Ser. II (May –June 2020), PP 10-15 www.Iosrjournals.Org A Review on Kuru: Fatal Neurodegenerative Disease Dr.Velicharla Raviteja1, Ms SaiSreeja Meka2 Department Of Pharm. D, Holy Mary Institute Of Technology And Science(College Of Pharmacy), Keesara, Hyderabad, Telangana-501 301 Abstract: Kuru, a very rare fatal neurodegenerative disease. It mainly affects the cerebellar region of the brain. It is caused by infectious proteins called prions. These prions are a deviant form of harmless protein. Kuru is a transmissible spongiform encephalopathy, prion disease. It is a human prion disease. The symptoms include tremors, loss of coordination, depression, muscle spasms and behavioural changes and ultimately lead to death. The incubation period of this disease varies from person to person and it could be as short as 5years and could be as long as 50 years. It is most prevalently seen in Papua New Guinea where a ritual of cannibalism is practiced, where most of the elderly women and children are affected as they are the one to whom human brain is given to consume during cannibalism. The neuropathological changes are observed on brain tissue during biopsy or after death. There is no treatment for this disease only supportive therapy is given. Moreover, this disease is almost vanished as there are no cases reported in recent years. The practice of cannibalism ritual was also banned by Australian government in 1960s. Keywords:kuru, neurodegenerative disease, prions, transmissible spongiform encephalopathy, tremors, cannibalism, biopsy.
  • Transmissibility Versus Pathogenicity of Self-Propagating Protein Aggregates

    Transmissibility Versus Pathogenicity of Self-Propagating Protein Aggregates

    viruses Review Transmissibility versus Pathogenicity of Self-Propagating Protein Aggregates Byron Caughey 1,* and Allison Kraus 2,* 1 Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA 2 Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA * Correspondence: [email protected] (B.C.); [email protected] (A.K.); Tel.: +1-406-363-9264 (B.C.) Received: 26 September 2019; Accepted: 6 November 2019; Published: 9 November 2019 Abstract: The prion-like spreading and accumulation of specific protein aggregates appear to be central to the pathogenesis of many human diseases, including Alzheimer’s and Parkinson’s. Accumulating evidence indicates that inoculation of tissue extracts from diseased individuals into suitable experimental animals can in many cases induce the aggregation of the disease-associated protein, as well as related pathological lesions. These findings, together with the history of the prion field, have raised the questions about whether such disease-associated protein aggregates are transmissible between humans by casual or iatrogenic routes, and, if so, do they propagate enough in the new host to cause disease? These practical considerations are important because real, and perhaps even only imagined, risks of human-to-human transmission of diseases such as Alzheimer’s and Parkinson’s may force costly changes in clinical practice that, in turn, are likely to have unintended consequences. The prion field has taught us that a single protein, PrP, can aggregate into forms that can propagate exponentially in vitro, but range from being innocuous to deadly when injected into experimental animals in ways that depend strongly on factors such as conformational subtleties, routes of inoculation, and host responses.
  • Genetic Studies in Relation to Kuru: an Overview

    Genetic Studies in Relation to Kuru: an Overview

    Current Molecular Medicine 2004, 4, 375-384 375 Genetic Studies in Relation to Kuru: An Overview L.G. Goldfarb*, L. Cervenakova and D.C. Gajdusek National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA American Red Cross J .H . Holland Laboratory , Rockville, MD 20855, USA Centre National de la Recharche Scientifique, Institut Alfred Fessard, Gif-sur-Yvette, France Abstract: Kuru is a subacute neurodegenerative disease presenting with limb ataxia, dysarthria, and a shivering tremor. The disease progress to complete motor and mental incapacity and death within 6 to 24 months. Neuropathologically, a typical pattern of neuronal loss, astrocytic and microglial proliferation, characteristic “kuru-type” amyloid plaques, and PrP deposits in the cerebral cortex and cerebellum are observed. Kuru is the prototype of a group of human transmissible spongiform encephalopathies (TSEs), or “prion” diseases, that include hereditary, sporadic and infectious forms. The latest member of this group, the variant Creutzfeldt-Jakob disease (vCJD), linked to transmission of bovine spongiform encephalopathy (BSE) to humans, shows features similar to kuru. Kuru has emerged at the beginning of the 1900s in a small indigenous population of New-Guinean Eastern Highlands, reached epidemic proportions in the mid-1950s and disappeared progressively in the latter half of the century to complete absence at the end of the 1990s. Early studies made infection, the first etiologic assumption, seem unlikely and led to a hypothesis that kuru might be a genetically determined or genetically mediated illness. After transmissibility of kuru had been discovered and all major epidemiologic phenomena adequately explained by the spread of an infectious agent with long incubation period through the practice of cannibalism, the pattern of occurrence still continued to suggest a role for genetic predisposition.
  • Prions in Variably Protease-Sensitive Prionopathy: an Update

    Prions in Variably Protease-Sensitive Prionopathy: an Update

    Pathogens 2013, 2, 457-471; doi:10.3390/pathogens2030457 OPEN ACCESS pathogens ISSN 2076-0817 www.mdpi.com/journal/pathogens Review Prions in Variably Protease-Sensitive Prionopathy: An Update Wen-Quan Zou 1,2,3,4,5,6,*, Pierluigi Gambetti 1,3, Xiangzhu Xiao 1, Jue Yuan 1, Jan Langeveld 7 and Laura Pirisinu 8 1 Department of Pathology Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA; E-Mails: [email protected] (P.G.); [email protected] (X.X.); [email protected] (J.Y.) 2 Department of Neurology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA 3 National Prion Disease Pathology Surveillance Center, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA 4 National Center for Regenerative Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA 5 The First Affiliated Hospital, Nanchang University, Nanchang 330006, Jiangxi Province, China 6 State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China 7 Central Veterinary Institute of Wageningen UR, Lelystad 8200 AB, the Netherlands; E-Mail: [email protected] (J.L.) 8 Department of Veterinary Public Health and Food Safety, Istituto Superiore di Sanità, Viale Regina Elena 299 00161, Rome, Italy; E-Mail: [email protected] (L.P.) * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel./Fax: +1-216-368-8993/+1-216-368-2546. Received: 12 June 2013; in revised form: 28 June 2013 / Accepted: 2 July 2013 / Published: 5 July 2013 Abstract: Human prion diseases, including sporadic, familial, and acquired forms such as Creutzfeldt-Jakob disease (CJD), are caused by prions in which an abnormal prion protein (PrPSc) derived from its normal cellular isoform (PrPC) is the only known component.
  • FRI BRIEFINGS Bovine Spongiform Encephalopathy

    FRI BRIEFINGS Bovine Spongiform Encephalopathy

    FRI BRIEFINGS Bovine Spongiform Encephalopathy An Updated Scientific Literature Review M. Ellin Doyle Food Research Institute University of Wisconsin–Madison Madison WI 53706 Contents Summary34B ......................................................................................................................................2 Bovine Spongiform Encephalopathy .........................................................................................4 BSE surveillance and detection..............................................................................................4 BSE in the UK........................................................................................................................4 BSE in Canada and the United States.....................................................................................5 BSE in other countries............................................................................................................5 BSE prions and pathogenesis .................................................................................................5 BSE in sheep ..........................................................................................................................6 BSE in other animals..............................................................................................................6 Other Spongiform Encephalopathies in Animals .....................................................................7 Scrapie....................................................................................................................................7
  • Breakthroughs in Antemortem Diagnosis of Neurodegenerative Diseases COMMENTARY Glenn C

    Breakthroughs in Antemortem Diagnosis of Neurodegenerative Diseases COMMENTARY Glenn C

    COMMENTARY Breakthroughs in antemortem diagnosis of neurodegenerative diseases COMMENTARY Glenn C. Tellinga,1 The World Health Organization forecasts that within 2 Abnormal cytoplasmic accumulation of a normally sol- decades neurodegenerative disorders will eclipse can- uble and unfolded protein called α-synuclein is the cer to become the foremost cause of death in the de- hallmark of diseases referred to as synucleinopathies. veloped world after cardiovascular disease. Accurate Neuronal deposition of α-synuclein aggregates in Lewy detection of pathological processes goes hand in hand bodies occurs in Parkinson’s disease (PD) and dementia with the goals of treatment and prevention and, in light with Lewy bodies (DLB). Yet another protein—the prion of their protracted but worsening clinical progression, protein (PrP)—is central to a group of interrelated dis- the earlier a diagnosis can be made the better. How- orders commonly referred to as prion diseases. ever, the challenge underlying accurate detection of Since the concept underlying the diagnostic ap- neurodegenerative diseases during their clinical phase proach taken by Metrick et al. (1) derives from studies is that specific biomarkers are not present at high of prions, it is worth reviewing what we have learned enough concentrations for routine detection in acces- about PrP and the applicability of these findings to sible specimens. Consequently, it has only been pos- other proteopathic diseases. The prion disorders are sible to definitively diagnose these conditions by transmissible neurodegenerative diseases affecting examination of brain pathology after death. The paper animals and humans. The most common human form by Metrick et al. (1) in PNAS addresses the issue of is Creutzfeldt–Jakob disease (CJD) which occurs most improved antemortem biomarker detection for a frequently as a sporadic, rapidly progressive condition spectrum of neurological disorders, using assays of older individuals.
  • The Epidemiology of Kuru: Monitoring the Epidemic from Its Peak to Its End Michael P

    The Epidemiology of Kuru: Monitoring the Epidemic from Its Peak to Its End Michael P

    CORE Metadata, citation and similar papers at core.ac.uk Provided by PubMed Central Phil. Trans. R. Soc. B (2008) 363, 3707–3713 doi:10.1098/rstb.2008.0071 Published online Review The epidemiology of kuru: monitoring the epidemic from its peak to its end Michael P. Alpers1,2,3,* 1Centre for International Health, ABCRC, Shenton Park Campus, Curtin University, GPO Box U1987, Perth, WA 6845, Australia 2MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK 3Papua New Guinea Institute of Medical Research, PO Box 60, Goroka, EHP 441, Papua New Guinea Kuru is a fatal transmissible spongiform encephalopathy restricted to the Fore people and their neighbours in a remote region of the Eastern Highlands of Papua New Guinea. When first investigated in 1957 it was found to be present in epidemic proportions, with approximately 1000 deaths in the first 5 years, 1957–1961. The changing epidemiological patterns and other significant findings such as the transmissibility of kuru are described in their historical progression. Monitoring the progress of the epidemic has been carried out by epidemiological surveillance in the field for 50 years. From its peak, the number of deaths from kuru declined to 2 in the last 5 years, indicating that the epidemic is approaching its end. The mode of transmission of the prion agent of kuru was the local mortuary practice of transumption. The prohibition of this practice in the 1950s led to the decline in the epidemic, which has been prolonged into the present century by incubation periods that may exceed 50 years.
  • Genetic Susceptibility, Evolution and the Kuru Epidemic

    Genetic Susceptibility, Evolution and the Kuru Epidemic

    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by PubMed Central Phil. Trans. R. Soc. B (2008) 363, 3741–3746 doi:10.1098/rstb.2008.0087 Published online Genetic susceptibility, evolution and the kuru epidemic Simon Mead1, Jerome Whitfield1,2,3, Mark Poulter1, Paresh Shah1, James Uphill1, Jonathan Beck1, Tracy Campbell1, Huda Al-Dujaily1, Holger Hummerich1, Michael P. Alpers1,2,3 and John Collinge1,* 1MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK 2Papua New Guinea Institute of Medical Research, PO Box 60, Goroka, EHP 441, Papua New Guinea 3Centre for International Health, ABCRC, Shenton Park Campus, Curtin University, GPO Box U1987, Perth, WA 6845, Australia The acquired prion disease kuru was restricted to the Fore and neighbouring linguistic groups of the Papua New Guinea highlands and largely affected children and adult women. Oral history documents the onset of the epidemic in the early twentieth century, followed by a peak in the mid- twentieth century and subsequently a well-documented decline in frequency. In the context of these strong associations (gender, region and time), we have considered the genetic factors associated with susceptibility and resistance to kuru. Heterozygosity at codon 129 of the human prion protein gene (PRNP) is known to confer relative resistance to both sporadic and acquired prion diseases. In kuru, heterozygosity is associated with older patients and longer incubation times. Elderly survivors of the kuru epidemic, who had multiple exposures at mortuary feasts, are predominantly PRNP codon 129 heterozygotes and this group show marked Hardy–Weinberg disequilibrium.
  • Balancing Selection at the Prion Protein Gene Consistent with Prehistoric Kurulike Epidemics Simon Mead,1 Michael P

    Balancing Selection at the Prion Protein Gene Consistent with Prehistoric Kurulike Epidemics Simon Mead,1 Michael P

    Balancing Selection at the Prion Protein Gene Consistent with Prehistoric Kurulike Epidemics Simon Mead,1 Michael P. H. Stumpf,2 Jerome Whitfield,1,3 Jonathan A. Beck,1 Mark Poulter,1 Tracy Campbell,1 James Uphill,1 David Goldstein,2 Michael Alpers,1,3,4 Elizabeth M. C. Fisher,1 John Collinge1* 1Medical Research Council, Prion Unit, and Department of Neurodegenerative Disease, Institute of Neurology, University College, Queen Square, London WC1N 3BG, UK. 2Department of Biology (Galton Laboratory), University College London, Gower Street, London WC1E 6BT, UK. 3Institute of Medical Research, Goroka, EHP, Papua New Guinea. 4Curtin University of Technology, Perth, WA, Australia. *To whom correspondence should be addressed. E-mail: [email protected] Kuru is an acquired prion disease largely restricted to the cannibalism imposed by the Australian authorities in the mid- Fore linguistic group of the Papua New Guinea Highlands 1950s led to a decline in kuru incidence, and although rare which was transmitted during endocannibalistic feasts. cases still occur these are all in older individuals and reflect Heterozygosity for a common polymorphism in the the long incubation periods possible in human prion human prion protein gene (PRNP) confers relative diseasekuru has not been recorded in any individual born after the late 1950s (4). resistance to prion diseases. Elderly survivors of the kuru A coding polymorphism at codon 129 of PRNP is a strong epidemic, who had multiple exposures at mortuary feasts, susceptibility factor for human prion diseases. Methionine are, in marked contrast to younger unexposed Fore, homozygotes comprise 37% of the UK population whereas predominantly PRNP 129 heterozygotes.
  • Variably Protease-Sensitive Prionopathy. Emerg Infect Dis 20: 2006–2014.)

    Variably Protease-Sensitive Prionopathy. Emerg Infect Dis 20: 2006–2014.)

    Handbook of Clinical Neurology, Vol. 153 (3rd series) Human Prion Diseases M. Pocchiari and J. Manson, Editors https://doi.org/10.1016/B978-0-444-63945-5.00010-6 Copyright © 2018 Elsevier B.V. All rights reserved Chapter 10 Variably protease-sensitive prionopathy SILVIO NOTARI1, BRIAN S. APPLEBY1,2,3,4, AND PIERLUIGI GAMBETTI1* 1Department of Pathology, Case Western Reserve University, Cleveland, OH, United States 2National Prion Disease Pathology Surveillance Center, Case Western Reserve University, Cleveland, OH, United States 3Department of Neurology, Case Western Reserve University, Cleveland, OH, United States 4Department of Psychiatry, Case Western Reserve University, Cleveland, OH, United States Abstract Variably protease-sensitive prionopathy (VPSPr), originally identified in 2008, was further characterized and renamed in 2010. Thirty-seven cases of VPSPr have been reported to date, consistent with estimated prevalence of 0.7–1.7% of all sporadic prion diseases. The lack of gene mutations establishes VPSPr as a sporadic form of human prion diseases, along with sporadic Creutzfeldt–Jakob disease (sCJD) and spo- radic fatal insomnia. Like sCJD, VPSPr affects patients harboring any of the three genotypes, MM, MV, and VVat the prion protein (PrP) gene polymorphic codon 129, with VPSPr VVaccounting for 65% of all VPSPr cases. Distinguishing clinical features include a median 2-year duration and presentation with psy- chiatric signs, speech/language impairment, or cognitive decline. Neuropathology comprises moderate spongiform degeneration, PrP amyloid miniplaques, and a target-like or plaque-like PrP deposition. The abnormal PrP associated with VPSPr typically forms an electrophoretic profile of five to seven bands (according to the antibody) presenting variable protease resistance depending on the 129 genotype.
  • Kuru: the Neurodegenerative Disorder; Roles of Prpc and Prpsc in Infection, Effects in Blocking Neural Synapses and Its Comprehensive Observation

    Kuru: the Neurodegenerative Disorder; Roles of Prpc and Prpsc in Infection, Effects in Blocking Neural Synapses and Its Comprehensive Observation

    ISSN: 2641-1911 DOI: 10.33552/ANN.2021.09.000717 Archives in Neurology & Neuroscience Research Article Copyright © All rights are reserved by Ahnaf Ilman Kuru: The Neurodegenerative Disorder; Roles of PrPC and PrPSc in infection, Effects in Blocking Neural Synapses and its Comprehensive Observation Ahnaf Ilman1* and Md. Abu Syed2 1Department of Science, Dhaka Residential Model College, Bangladesh 2Department of English, Dhaka Residential Model College, Bangladesh *Corresponding author: Ahnaf Ilman, Founder & President, Organization for Received Date: December 10, 2020 Natural Science Research; Department of Science, Dhaka Residential Model College, Dhaka, Bangladesh. Published Date: January 08, 2021 Abstract Kuru is a rare and neurodegenerative disorder-creating disease that effectively and principally affects Neural Synapses and the Central Nervous System. For this reason, brain cells and tissues started to be damaged and deceased. Microbials step out to act against the dangerous deceased cells of the human brain, and spongiform encephalopathy gets created. Thus, the Axon-Dendron of Neuron that contains the human brain gets blocked. In the mid of 19s, Kuru has been revealed as a complicated and a suspected pandemic creating disease. Although most of the diseases are caused protein. Human body also bears protein, but that is a normal and not dangerous protein, and it is regarded as Cellular Prion Protein, also known as PrPby differentC. That protein types ofdonates virus, itselfbacteria, for thefungus betterment etc., Kuru of isthe the human first human body. But transmitted the Scrapie disease Prion that Protein has beenalso known caused as by PrPS a complicatedc is the Prion and Protein misfolded that causes Kuru Disease and acts against the Brain and Immune System.
  • Prion Diseases Kuru

    Prion Diseases Kuru

    Infectious Agents and Slow Degenerative Diseases of the CNS Viral Diseases Prion Diseases Measles (Subacute Sclerosing Scrapie Prion Diseases Panencephalitis) Mad Cow HIV (HIV-D, HIV dementia) Creutzfeldt-Jakob HTLV-I Myelopathy Fatal familial insomnia JC and BK (Progressive multifocal Gerstmann-Straussler Scheinker leukoencephalopathy) Rubella panencephalitis Rabies Canine distemper virus Steve Udem, M.D., Ph.D. VP Wyeth Vaccines Discovery Brain Histology Kuru Papua New Guinea Kuru Kuru Disease affects the Tribe Walking Sticks 1 Kuru Kuru Mother & Disease daughter strikes children Clinical features of Kuru Spongiform Encephalopathy - Histology Transmission Autoinoculation/ingestion of infected brain material Prevalence Fore linguistic group of Papua New Guinea Clinical features Cerebellar ataxia, tremor, movement disorders Mental impairment, emotional lability, frontal release signs (snout, suck, root, grasp reflexes) Course Fatal 9-24 months after onset Linking Kuru to an Infectious Agent (Gajdusek) Prion Diseases Pathogenic PrP Disease Natural Host Prion Isoform Scrapie Sheep and goats Scrapie Prion OvPrPSc Transmissible mink encephalopathy (TME) Mink TME Prion MkPrPSc Chronic wasting disease (CWD) Deer and elk CWD Prion MdePrPSc Bovine spongiform encephalopathy (BSE) Cattle BSE Prion BoPrPSc Feline spongiform encephalopathy (FSE) Cats FSE Prion FePrPSc Exotic ungulate encephalopathy (EUE) Nyala & greater kudu EUE Prion UngPrPSc Kuru Humans Kuru Prion HuPrPSc Creutzfeldt-Jakob disease (CJD) Humans CJD Prion HuPrPSc Gerstmann-Staussler-Scheinker